Monash IVF Group Limited announced the appointment of Ms. Cathy Aston as an Independent Non-Executive Director and a member of the Audit and Risk Management Committee effective from 26 February 2024. Cathy is an experienced ASX listed non-executive director and has over 20 years' experience in executive roles across finance, marketing, strategy and technology, both in Australia and Asia. Cathy is very familiar with the IVF industry, serving on the Board of Virtus Health until its takeover in 2022.

Cathy's executive roles were in the telecommunications industry, predominantly at Telstra where she worked for over 20 years. During her time at Telstra her senior roles were varied, initially focussing on finance, and over time transitioning to strategic roles across marketing, customer experience and technology. A key focus for Cathy was enabling businesses to improve their service offerings and customer experience through the use of technology.

Cathy has significant experience in international expansion, in particularly in Asia, having worked in Hong Kong, Sri Lanka and India. Over the past decade Cathy has been very active in non-executive and advisory roles. Cathy is a non- executive director of ASX listed Integrated Research (Chair of the Audit and Risk Committee), IVE Group (Chair of the Risk and Compliance Committee), Macquarie Investment Management (Chair of the Audit, Risk and Compliance Committee) and IMB Bank (Chair).

Previously she was on the Board of Virtus Health. Cathy's advisory roles have included work with the NSW State Government, and an Advisory Board Member of Avanseus, a Singapore based AI business. Cathy has a Bachelor of Economics (Macquarie University) and a Master of Commerce, Accounting & Law (University of NSW).

She is a Graduate of the Australian Institute of Company Directors and a Senior Fellow of the Financial Services Institute of Australasia (FINSIA).